Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2018
Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell TransplantationRossana Mineri, Jacopo Mariotti, Barbara Sarina, et al.
Haematologica|January 19, 2007
Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphomaArmando Santoro, Massimo Magagnoli, Michele Spina, et al.
American Journal of Hematology|October 5, 2006
Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective studyLuca Castagna, Massimo Magagnoli, Monica Balzarotti, et al.
European Journal of Haematology|February 23, 2007
CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patientsElisabetta Todisco, Luca Castagna, Barbara Sarina, et al.
British Journal of Haematology|July 22, 2025
Allogeneic transplantation after failure of chimeric antigen receptor-T cells and exposure to bispecific antibodies: Feasibility, safety and survival outcomesAngelica Barone, Chiara De Philippis, Federico Stella, et al.
Transfusion|March 30, 2016
Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantationStefania Bramanti, Angela Nocco, Elisa Mauro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2014
Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantationElisa Sala, Roberto Crocchiolo, Sara Gandolfi, et al.
Cytotherapy|November 15, 2025
A FOXP3+ cell-rich microenvironment associates with better overall survival after CAR-T cell therapy in relapsed/refractory B-cell lymphomaSimone Zanella, Cristina Zucchinetti, Chiara de Philippis, et al.
Practical Radiation Oncology|March 13, 2020
Development of an Immobilization Device for Total Marrow IrradiationPietro Mancosu, Pierina Navarria, Ludvig Paul Muren, et al.
Cancers|June 26, 2026
Stem Cell Mobilization and Autologous Transplantation Outcomes After First-Line R-DA-EPOCH in High-Risk DLBCL and HGBCL: A Single-Center Retrospective StudyDaniela Taurino, Giulia Figini, Francesca Ricci, et al.
Pageof 7